Not sure if posted already...
https://www.watoday.com.au/business/companies/not-for-the-faint-hearted-covid-crisis-brings-boom-time-for-biotechs-20200813-p55l93.html
Not for the faint-hearted': COVID crisis brings boom time for biotechs
By Emma Koehn
AUGUST 14, 2020
Mesoblast boss and major shareholder Silviu Itescu won’t be the only one breathing easier now that the ASX-listed biotech’s flagship treatment has managed to get the green light from the US regulator’s advisory committee.
It was a close run thing by all accounts and for Itescu and investors in Mesoblast a no vote would have seen a decade’s worth of work come to a standstill.
For his part, Itescu says he wasn’t quite as spooked as investors by signs the US Food and Drug Administration's drug advisory council was going to put Mesoblast’s treatment under severe scrutiny.
“We have been very well prepared for this meeting, we have known what the issues are and we’ve known what the answers are,” he says.
(article continues - see link above)
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-5702
-
- There are more pages in this discussion • 12,323 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16000 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.0¢ | 86854 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16000 | 0.965 |
1 | 23000 | 0.960 |
8 | 163220 | 0.955 |
8 | 87646 | 0.950 |
3 | 82684 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.970 | 86854 | 7 |
0.975 | 37184 | 2 |
0.980 | 44810 | 6 |
0.985 | 88504 | 4 |
0.990 | 54328 | 5 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online